ArticleJournal of inflammation research2025

Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors.

Yan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.